AI-generated analysis. Always verify with the original filing.
Sanara MedTech Inc. reported fourth quarter 2025 net revenue of $27.5 million, up 5% from $26.3 million in Q4 2024, and full year 2025 net revenue of $103.1 million, up 19% from $86.7 million in 2024, with Adjusted EBITDA of $17.0 million. The company reaffirmed full year 2026 net revenue guidance of $116 million to $121 million.
Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On March 24, 2026, Sanara MedTech Inc. (the “Company”) issued a press release announcing its financial results fo
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued March 24, 2026 (furnished pursuant to Item 2.02). 104 Cover Pa
| Metric | Value | Basis |
|---|---|---|
| Net revenue | $27.50 | GAAP |
| Net revenue | $103.10 | GAAP |
| Gross profit | $25.70 | GAAP |
| Gross margin | 93% | GAAP |
| Operating income | $1.10 | GAAP |
| Net income (loss) from continuing operations | $-1.10 | GAAP |
| Net income (loss) from continuing operations | $-0.40 | GAAP |
| Adjusted EBITDA | $4.70 | Non-GAAP |
| Adjusted EBITDA | $17.00 | Non-GAAP |
Net revenue
116 to 121